Get Real Time Here
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Haemonetics Stock (NYSE:HAE), Quotes and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
| Open88.900 | Close- |
| Vol / Avg.20.845K / 292.585K | Mkt Cap4.499B |
| Day Range88.130 - 89.500 | 52 Wk Range72.260 - 95.260 |
Earnings
see more| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.890 | (EXPECTED) 2023-11-06 | |||||
| REV | 313.560M | ||||||
| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.760 | 1.050 | 0.2900 | ||||
| REV | 297.920M | 311.332M | 13.412M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-09 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 111.00 | 114.00 |
| 2023-05-12 | Barrington Research | Michael Petusky | Maintains | OutperformOutperform | Raises | 103.00 | 111.00 |
| 2023-05-12 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Raises | 88.00 | 96.00 |
| 2023-05-12 | JMP Securities | David Turkaly | Maintains | Market OutperformMarket Outperform | Raises | 105.00 | 115.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HAE | Haemonetics | -0.97% | 4.5B |
| TELA | TELA Bio | -5.13% | 185.9M |
| RXST | RxSight | 0% | 994.1M |
| EMBC | Embecta | -1.46% | 849.8M |
| ALGN | Align Tech | -1.22% | 23.1B |
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Who are Haemonetics's (HAE) competitors?
Other companies in Haemonetics’s space includes: TELA Bio (NASDAQ:TELA), RxSight (NASDAQ:RXST), Embecta (NASDAQ:EMBC), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
What is the target price for Haemonetics (HAE) stock?
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Wednesday, August 9, 2023. The analyst firm set a price target for 114.00 expecting HAE to rise to within 12 months (a possible 28.51% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $88.71 last updated Today at October 2, 2023 at 3:19 PM UTC.
Does Haemonetics (HAE) pay a dividend?
There is no dividend information for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q2 earnings are confirmed for Monday, November 6, 2023.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.